Lawrence J. Green MD

Acne & Rosacea, Cosmetic Dermatology, Dermatologic Surgery

Clinical Professor of Dermatology, Geo Wash University

9601 Blackwell RdSuite 260Rockville, MD 20850
Phone+1 301-610-0663
Fax+1 301-610-5420

Dr. Green is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Green's full profile Already have an account?

Summary

Dr. Lawrence Green is a board certified dermatologist in Rockville, MD and oversees a large clinical trial center at his practice. He received his medical degree from New York Medical College, and completed a Dermatology and Skin Surgery residency at the Univ of California, Irvine. He has been in practice 28 years. He is a past member of the Board of Directors for the American Academy of Dermatology and the American Society for Dermatologic Surgery. Dr Green is also a past President of the Montgomery County Medical Society. He is current Chair of the Research Committee and a member of the Board of Directors for the National Psoriasis Foundation. Dr Green has more than 100 publications and over 500 citings.

Education & Training

University of California (Irvine)Residency, Dermatology, 1990 - 1995
Westchester Medical CenterInternship, Internal Medicine, 1989 - 1990
University of Michigan Medical SchoolB.A., English, 1981 - 1989
New York Medical CollegeClass of 1989
University of MichiganBA, Honors English, 1981 - 1985

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MD State Medical License 1996 - 2028
CA State Medical License 1990 - 2027
DC State Medical License 1996 - 2027
VA State Medical License 1995 - 2026
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification athenaClinicals, athenahealth, Inc., 2017
Top Doctors:Baltimore Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012

Clinical Trials

A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis
COMPLETED
PHASE3
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
COMPLETED
PHASE2
Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis
COMPLETED
PHASE3

Publications & Presentations

PubMed

Roflumilast foam versus vehicle foam for seborrheic dermatitis (STRATUM clinical study): a plain language summary.
Andrew Blauvelt, Zoe D Draelos, Linda Stein Gold, Javier Alonso-Llamazares, Neal Bhatia
The Journal of Dermatological Treatment. 2026-12-01
2 citations
Efficacy and safety of ruxolitinib cream combined with narrow-band UVB phototherapy for treatment of vitiligo.
Amit G Pandya, Charles W Lynde, Maryam Shayesteh Alam, Ira H Thorla, Katherine Reed
The Journal of Investigative Dermatology. 2026-07-01
6 citations
Tapinarof cream 1% once daily was well tolerated in adults and children with atopic dermatitis in two phase 3 randomized trials.
Linda Stein Gold, James Del Rosso, Benjamin D Ehst, Matthew J Zirwas, Lawrence J Green
The Journal of Dermatological Treatment. 2025-12-01

Journal Articles

Who Do You Prefer? A Study of Public Preferences for Health Care Provider Type in Performing Cutaneous Surgery and Cosmetic Procedures in the United States
Derm Surg, 1/1/2014
Evaluation of the Efficacy, Tolerability, and Safety of an Over the Counter Acne Regimen Containing Benzoyl Peroxide and Salicylic Acid in Patients with Acne
J Drugs in Dermatology, 1/1/2013
A multicenter double masked placebo controlled study assessing patient satisfaction with bimotoprost ophthalmic solution 003% for increasing eyelash prominence
J American Academy of Dermatology, 1/1/2013

Abstracts/Posters

A multicenter double masked placebo controlled study assessing patient satisfaction with bimotoprost ophthalmic solution 0.03% for increasing eyelash prominence
American Academy of Dermatology Annual Meeting
, 1/1/2013
Clinical evidence for the role of a topical anti-inflammatory agent in Comedonal acne: Findings From a study of Dapsone 0.5% gel in combination with Tazarotene 0.1% cr...
Fall Clinical Dermatology Meeting, 1/1/2010
Comparing a Novel Solubilized Benzoyl Peroxide Gel with Benzoyl Peroxide/Clindamycin: Final Data From a Multicenter Investigator Blind Randomized Study
Summer American Academy of Dermatology meeting, 1/1/2008

Lectures

The Role of and Topical Therapies Involving Androgen Hormones in Acne and Androgenetic Alopecia (AGA)
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
Safety and efficacy of Radiesse to improve aging hands
1/1/2015
Safety and efficacy of secukinamab to treat moderate to severe plaque psoriasis
1/1/2015

Press Mentions

Study Examines Acne Relapse and Isotretinoin RetrialJanuary 17th, 2025
Telehealth for High-Risk, Immunocompromised Patients: How to See Your Doctor Virtually During the Coronavirus PandemicMarch 24th, 2020
Steroid Creams Sold Over-the-Counter Can Be DangerousJanuary 24th, 2020